Boston Scientific’s Ingevity™ Pacing Lead Trial Sees First Patient



Boston Scientific Begins Clinical Trial of Patients Implanted with INGEVITY™ Pacing Leads (via PR Newswire)

NATICK, Mass., Dec. 17, 2012 /PRNewswire/ — The first patient has been implanted with the Boston Scientific Corporation (NYSE: BSX) next generation INGEVITY™ pacing leads in a clinical trial designed to establish the safety, performance and effectiveness of the leads.  Pacing leads are insulated…